COLO-DETECT
Research type
Research Study
Full title
COLO-DETECT: A Randomised Controlled Trial of Lesion Detection at Colonoscopy Using the GI Genius™ Artificial Intelligence Platform
IRAS ID
286426
Contact name
Colin Rees
Contact email
Sponsor organisation
South Tyneside and Sunderland NHS Foundation Trust
Clinicaltrials.gov Identifier
Clinicaltrials.gov Identifier
ClinicalTrials.gov, Pending
Duration of Study in the UK
1 years, 6 months, 0 days
Research summary
Bowel cancer (also known as colorectal cancer) is common in the UK, affecting around 1 in 15 men and 1 in 18 women at some point in their lifetime. Many colorectal cancers develop from polyps (small growths of the bowel lining). Some polyps can develop into cancer over a period of time, the most common type of polyp to do this is called an adenoma. Polyps can be detected and removed during a camera test (called a colonoscopy) before they become cancerous.
GI Genius™ is an Artificial Intelligence technology device designed to assist the person performing the colonoscopy in identifying polyps so that they may be removed, thus reducing the risk of future bowel cancer. The GI Genius™ is a box that integrates with existing colonoscopy equipment; it analyses the video feed from the colonoscope in real-time and highlights any area of the bowel lining that may be abnormal within a green box. This enables the person performing the colonoscopy to inspect the area more closely and if a polyp is identified, it can then be removed if appropriate. The GI Genius™ does not affect the size or function of the colonoscope in any other way.
The COLO-DETECT study is a clinical randomised controlled trial investigating the ability of colonoscopy assisted by GI Genius™ to detect polyps (and in particular, adenomas), when compared to standard colonoscopy.
REC name
West of Scotland REC 4
REC reference
21/WS/0003
Date of REC Opinion
25 Jan 2021
REC opinion
Further Information Favourable Opinion